Chikungunya Virus VLP Vaccine: Phase 3 Trial in Adolescents and Adults
Jason S. Richardson, Deborah M. Anderson, Jason Mendy, View ORCID ProfileLauren C. Tindale, Sufia Muhammad, Tobi Loreth, Sarah Royalty Tredo, Kelly L. Warfield, Roshan Ramanathan, Jorge T. Caso, Victoria A. Jenkins, Patrick Ajiboye, Lisa Bedell, the EBSI-CV-317-004 Study Group
doi: https://doi.org/10.1101/2024.10.11.24315179
Jason S. Richardson
1Bavarian Nordic Canada Inc., Toronto, Ontario, Canada
PhDDeborah M. Anderson
1Bavarian Nordic Canada Inc., Toronto, Ontario, Canada
MSJason Mendy
2Bavarian Nordic Inc., San Diego, California, USA
MSLauren C. Tindale
1Bavarian Nordic Canada Inc., Toronto, Ontario, Canada
PhDSufia Muhammad
2Bavarian Nordic Inc., San Diego, California, USA
MDTobi Loreth
1Bavarian Nordic Canada Inc., Toronto, Ontario, Canada
BASarah Royalty Tredo
3Emergent BioSolutions, Gaithersburg, Maryland, USA
MBAKelly L. Warfield
3Emergent BioSolutions, Gaithersburg, Maryland, USA
PhDRoshan Ramanathan
3Emergent BioSolutions, Gaithersburg, Maryland, USA
MD, MPHJorge T. Caso
4Suncoast Research Associates, LLC, Miami, Florida USA
MDVictoria A. Jenkins
5Bavarian Nordic Belgium, Brussels, Belgium
PhDPatrick Ajiboye
2Bavarian Nordic Inc., San Diego, California, USA
MDLisa Bedell
2Bavarian Nordic Inc., San Diego, California, USA
MA
Posted October 15, 2024.
Chikungunya Virus VLP Vaccine: Phase 3 Trial in Adolescents and Adults
Jason S. Richardson, Deborah M. Anderson, Jason Mendy, Lauren C. Tindale, Sufia Muhammad, Tobi Loreth, Sarah Royalty Tredo, Kelly L. Warfield, Roshan Ramanathan, Jorge T. Caso, Victoria A. Jenkins, Patrick Ajiboye, Lisa Bedell, the EBSI-CV-317-004 Study Group
medRxiv 2024.10.11.24315179; doi: https://doi.org/10.1101/2024.10.11.24315179
Chikungunya Virus VLP Vaccine: Phase 3 Trial in Adolescents and Adults
Jason S. Richardson, Deborah M. Anderson, Jason Mendy, Lauren C. Tindale, Sufia Muhammad, Tobi Loreth, Sarah Royalty Tredo, Kelly L. Warfield, Roshan Ramanathan, Jorge T. Caso, Victoria A. Jenkins, Patrick Ajiboye, Lisa Bedell, the EBSI-CV-317-004 Study Group
medRxiv 2024.10.11.24315179; doi: https://doi.org/10.1101/2024.10.11.24315179
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2880)
- Dermatology (247)
- Emergency Medicine (432)
- Epidemiology (12617)
- Forensic Medicine (10)
- Gastroenterology (812)
- Genetic and Genomic Medicine (4482)
- Geriatric Medicine (409)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (378)
- HIV/AIDS (910)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4244)
- Nursing (228)
- Nutrition (622)
- Oncology (2225)
- Ophthalmology (633)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (490)
- Pediatrics (1182)
- Primary Care Research (487)
- Public and Global Health (6828)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (376)
- Surgery (475)
- Toxicology (60)
- Transplantation (206)
- Urology (176)